Adverse Event Reporting

VAERS ID 1114301
Gender Male
Age 23
StateCode KS
Pharmaceutical Company PFIZER\BIONTECH
Lot Number EN5318
Number of vaccinations 2
Vaccinated 2021-02-15
Onset 2021-02-15
Condition
Symptoms
  • Dizziness
  • Chills
  • Chest pain
  • Cold sweat
  • Migraine
  • Dehydration
  • SARS-CoV-2 antibody test

Current Illness

Preexisting Conditions

Other Medications

Previous Vaccinations

Allergies

Laboratory Data

Test Date: 20210211; Test Name: Nasal Swab; Test Result: Negative

Write-up

Chest Pain; Chills; Migraine; Cold Sweat; Light Headedness; Dehydration; This is a spontaneous report from a contactable consumer, the patient.
A 23-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EN5318), via an unspecified route of administration in the left arm on 15Feb2021 at 08:15 (at the age of 23-years-old) as a single dose for COVID-19 vaccination.
The patient had no relevant medical history reported.
The patient did not have any known allergies.
The patient's concomitant medications were not reported.
The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EN5318), via an unspecified route of administration in the left arm on 25Jan2021 at 08:15 (at the age of 23-years-old) for COVID-19 vaccination.
The patient did not receive any other vaccine within 4 weeks prior to the vaccine or any other medications within two weeks of vaccine.
The patient did not have COVID-19 prior to the vaccination.
The patient was tested for COVID-19 on 11Feb2021 with nasal swab and the result was negative.
On 15Feb2021 at 20:30 the patient experienced chills, migraine, cold sweat, chest pain, light headedness, and dehydration.
The patient did not receive any treatment for the chills, migraine, cold sweat, chest pain, light headedness, and dehydration.
The clinical outcome of the chills, migraine, cold sweat, chest pain, light headedness, and dehydration was not recovered.